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Abstract
Background  and  objectives: Neuraxial  anesthesia  (NA)  has  been  used  in  association  with  general
anesthesia  (GA)  for  coronary  artery  bypass;  however,  anticoagulation  during  surgery  makes  us
question the  viability  of  beneﬁts  by  the  risk  of  epidural  hematoma.  The  aim  of  this  study  was
to perform  a  meta-analyzes  examining  the  efﬁcacy  of  NA  associated  with  GA  compared  to  GA
alone for  coronary  artery  bypass  on  mortality  reduction.
Methods:  Mortality,  arrhythmias,  cerebrovascular  accident  (CVA),  myocardial  infarction  (MI),
length of  hospital  stay  (LHS),  length  of  ICU  stay  (ICUS),  reoperations,  blood  transfusion  (BT),
quality of  life,  satisfaction  degree,  and  postoperative  cognitive  dysfunction  were  analyzed.  The
weighted mean  difference  (MD)  was  estimated  for  continuous  variables,  and  relative  risk  (RR)
and risk  difference  (RD)  for  categorical  variables.
Results:  17  original  articles  analyzed.  Meta-analysis  of  mortality  (RD  =  −0.01,  95%  CI  =  −0.03
to 0.01),  CVA  (RR  =  0.79,  95%  CI  =  0.32--1.95),  MI  (RR  =  0.96,  95%  CI  =  0.52--1.79)  and  LHS
(MD =  −1.94,  95%  CI  =  −3.99  to  0.12)  were  not  statistically  signiﬁcant.  Arrhythmia  was  less  fre-
quent with  NA  (RR  =  0.68,  95%  CI  =  0.50--0.93).  ICUS  was  lower  in  NA  (MD  =  −2.09,  95%  CI  =  −2.92
to −1.26).
Conclusion:  There  was  no  signiﬁcant  difference  in  mortality.  Combined  NA  and  GA  showed  lowerd  lower  ICUS.
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Efetividade  da  associac¸ão  da  anestesia  regional  à  anestesia  geral  na  reduc¸ão
da  mortalidade  em  revascularizac¸ão  miocárdica:  metanálise
Resumo
Introduc¸ão  e  objetivos:  A  anestesia  neuroaxial  (AN)  vem  sendo  utilizada  em  associac¸ão  com  a
anestesia geral  (AG)  para  revascularizac¸ão  miocárdica,  entretanto  a  anticoagulac¸ão  durante
a cirurgia  torna  questionável  a  viabilidade  dos  benefícios  mediante  o  risco  de  hematoma  de
espac¸o peridural.  O  objetivo  deste  estudo  foi  executar  metanálises  analisando  a  efetividade
da AN  associada  à  AG  comparada  à  AG  isolada  para  a  cirurgia  de  revascularizac¸ão  miocárdica
relativa à  reduc¸ão  da  mortalidade.
Métodos:  Foram  analisados  mortalidade,  arritmias,  acidente  vascular  cerebral  (AVC),  infarto
miocárdico (IM),  tempo  de  internac¸ão  hospitalar  (TIH),  tempo  de  internac¸ão  em  unidade  de
terapia intensiva  (TUTI),  reoperac¸ões,  transfusão  sanguínea  (TS),  qualidade  de  vida,  grau  de
satisfac¸ão e  disfunc¸ão  cognitiva  pós-opertória.  A  diferenc¸a  média  (DM)  ponderada  foi  estimada
para as  variáveis  contínuas  e  risco  relativo  (RR)  e  a  diferenc¸a  de  risco  (DR)  para  variáveis
categóricas.
Resultados:  Analisados  17  artigos  originais.  Metanálise  da  mortalidade  (DR  =  −0,01;  IC
95% =  −0,03  a  0,01),  AVC  (RR  =  0,79;  IC  95%  =  0,32  a  1,95),  IM  (RR  =  0,96;  IC  95%  =  0,52  a  1,79)
e TIH  (DM  =  −1,94;  IC  95%  =  −3,99  a  0,12)  não  demonstraram  signiﬁcância  estatística.  Arritmia
foi menos  frequente  com  AN  (RR  =  0,68;  IC  95%  =  0,50  a  0,93).  O  TUTI  foi  menor  no  com  AN
(DM =  −2,09;  IC  95%  =  −2,92  a  −1,26).
Conclusão:  Não  se  observaram  diferenc¸as  estatisticamente  signiﬁcantes  quanto  a  mortalidade.
A combinac¸ão  de  AN  e  AG  mostrou  menor  incidência  de  arritmias  e  menor  TUTI.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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oronary  artery  bypass  grafting  occurs  in  approximately
00,000  patients  annually.1 There  is  an  increased  inter-
st  in  the  use  of  neuraxial  anesthesia  (NA),  spinal  and
pidural  anesthesia,  associated  with  general  anesthesia
GA)  for  coronary  artery  bypass,  which  is  also  a  matter
or  further  research  worldwide.2 The  risks  and  bene-
ts  of  NA  in  this  setting  have  been  reviewed  in  adult
atients.2
One  of  the  beneﬁts  of  NA  is  to  mitigate  the  response
o  surgical  stress  due  to  blockage  of  cardioaccelerator
bers,  T1  to  T5,  and  improved  coronary  response  to
asodilators  improving  the  balance  between  the  supply
nd  consumption  of  myocardial  oxygen.2,3 Sympathetic
ctivation  is  considered  the  main  mechanism  for  the  occur-
ence  of  new  myocardial  infarction  in  the  postoperative
eriod.3
The  use  of  NA  in  heart  surgery  is  still  controversial  due
o  the  possibility  of  hematoma  or  abscess  at  the  puncture
ite  and  the  possibility  of  spinal  compression.4 The  current
ata  available  in  the  literature  were  used  in  mathematical
odels  to  estimate  the  maximum  risk  of  this  event  after
ull  heparinization,  which  was  estimated  at  1:2400  with  full
eparinization.4The  aim  of  this  study  was  to  perform  a  meta-analyzes
o  evaluate  the  effectiveness  of  neuraxial  anesthesia
ssociated  with  general  anesthesia  compared  to  general
f
A
Jnesthesia  alone  for  coronary  artery  bypass  grafting
egarding  the  reduction  of  mortality.
ethod
ystematic  review  was  performed  following  a  protocol
eveloped  prior  of  the  performing  this  review.  This  proto-
ol,  as  well  as  the  review  performance,  followed  the  steps
uggested  by  The  Preferred  Reporting  Items  for  Systematic
eviews  and  Meta-Analysis  (PRISMA)  statement.5 The  stages
f  this  research  were:  systematic  literature  search,  careful
nalysis  for  inclusion  and  exclusion  of  studies,  analysis  of
he  quality  of  studies,  data  collection  of  outcome  variables,
eta-analytic  calculations,  analysis  of  sensitivity  and  homo-
eneity,  and  trial  sequential  analysis.  All  stages  performed
re  described  below.
earch  strategy
he  identiﬁcation  and  systematic  search  for  potentially
elevant  original  articles  was  performed  in  the  following
atabases:  Medline  via  PubMed  from  January  1966  to  Jan-
ary  2014,  Cochrane  Central  Register  of  Controlled  Trialsrom  January  1974  to  January  2014,  and  Literatura  Latino-
mericana  e  do  Caribe  em  Ciências  da  Saúde  (Lilacs)  from
anuary  1982  to  January  2014.  The  references  of  included
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studies  were  also  analyzed  for  articles  that  had  the  poten-
tial  to  be  part  of  this  review,  but  they  were  not  identiﬁed  in
the  electronic  databases.  We  searched  for  published  studies
comparing  the  use  of  NA  associated  with  GA  and  GA  alone
for  coronary  artery  bypass  grafting.  The  following  terms
were  used  in  different  combinations:  Anesthesia,  General;
Anesthesias,  Intravenous; neuraxial  anesthesia, Anesthesia;
Epidural, anesthesia, spinal, thoracic  surgical  procedures,
and  clinical  trials  as  topic. The  search  was  limited  to  clini-
cal  trials  of  random  allocation  that  included  adult  patients
(over  18  years  old)  who  underwent  surgery  only  for  coronary
artery  bypass.  There  was  no  language  restriction.
Inclusion  and  exclusion  criteria  of  the  studies
Inclusion  criteria  were  clinical  trials  with  random  allocation
that  assessed  patients  undergoing  coronary  artery  bypass
and  compared  the  NA  techniques  associated  with  GA  and
GA  alone  with  or  without  catheter.
Exclusion  criteria  were  original  articles  of  clinical  trials
with  inadequate  description  of  variables  of  interest  for  this
review,  when  the  allocation  for  coronary  artery  bypass  graft-
ing  was  associated  with  another  type  of  surgery,  when  the
variables  were  not  of  interest  to  this  systematic  review,  and
when  an  intervention  other  than  NA  or  GA  was  used  in  the
patients  studied.
Studies  initially  identiﬁed  by  reading  the  titles  and
abstracts  that  seemed  relevant  to  this  review  were  grouped
together  for  full  reading  by  two  reviewers.  Disagreements
were  resolved  by  consensus  meetings.  If  the  disagreements
were  not  resolved,  the  participation  of  a  third  author  was
planned,  but  it  was  not  necessary.
Critical  analysis  of  the  studies’  quality
and classiﬁcation
The  classiﬁcation  of  studies  was  carried  out  individually  and
independently  by  two  reviewers,  who  scored  the  original
articles  according  to  its  methodological  quality,  according  to
the  criteria  of  Jadad.6 The  evaluated  criteria  were  random
assignment  of  subjects  to  groups,  adequacy  of  the  random
allocation,  concealment  of  individuals  in  groups,  adequacy
of  concealment  of  individuals  and  the  description  of  losses
and  exclusions.  A  total  of  5  points  could  be  achieved  with
good  quality  articles  being  considered  those  that  reach  more
than  2 points.  This  criterion  was  not  used  to  exclude  original
articles  of  meta-analytic  review.
The  Agreement  Kappa  Index  was  used  to  assess  whether
there  has  been  agreement  among  the  reviewers  or  if  their
analysis  were  consistent  among  themselves.  This  statistical
test  was  used  considering  a  statistical  power  of  80%  and  type
I  error  probability  of  5%.  The  values  of  this  test  may  vary
between  0  and  1  with  0  being  the  absence  of  agreement  and
1  perfect  agreement  between  reviewers.  Values  above  0.8
were  considered  as  good  agreement  between  reviewers.Outcome  variables  and  data  extraction  method
The  primary  outcome  variable  was  mortality.  The  vari-
able  mortality  was  considered  for  the  ﬁrst  7  days  of
a
c
p
t185
ospitalization  (immediate),  between  7  and  30  days  after
urgery  (early),  and  after  1  year  of  follow-up  (late).  Sec-
ndary  outcome  variables  were  arrhythmias,  stroke,  acute
yocardial  infarction,  length  of  hospital  stay  measured  in
ays,  length  of  intensive  care  unit  stay  measured  in  days,
eoperation  frequency,  blood  transfusion  measured  by  the
umber  of  participants  who  received  blood  transfusion,
uality  of  life,  degree  of  satisfaction,  and  postoperative
ognitive  dysfunction.
Two  reviewers  independently  collected  the  data.  One  of
he  reviewers  entered  the  data  into  a computer  program  and
ater,  in  a  second  stage,  the  other  reviewer  who  collected
he  data  checked  to  prevent  the  insertion  of  exchanged
umbers  into  the  computer  program.  The  meta-analytic  cal-
ulations  were  performed  only  after  the  checking  by  the
econd  reviewer.
eta-analysis
he  Review  Manager  software  was  used  to  perform  the
eta-analysis  calculations.7 It  was  planned  to  calculate  the
agnitude  of  the  interventions’  effect  and  the  respective
5%  conﬁdence  intervals  (95%  CI)  for  dichotomous  variables
sing  relative  risk  (RR),  however,  if  the  event  frequency
as  absent  in  an  analyzed  variable  included  in  the  origi-
al  article,  the  risk  difference  (RD)  was  used.  The  interval
ariables  were  evaluated  by  mean  differences  (MD).  The
andom-effects  model  was  applied  for  meta-analytic  calcu-
ations.  Statistical  heterogeneity  was  quantiﬁed  using  the
2 test.  When  the  values  of  I2 were  greater  than  30%,  the
esults  were  considered  heterogeneous.
Publication  bias  was  investigated  by  the  analysis  of
nverted  funnel  plot.8 The  original  article  from  the  published
tudy  that  has  been  identiﬁed  as  a  source  of  publication
ias  for  the  results  was  excluded  during  the  analysis  of  sen-
itivity  and  homogeneity.  The  original  articles  used  in  the
alculations  were  indicated  by  the  last  name  of  the  ﬁrst
uthor  followed  by  the  year  of  publication  to  present  the
eta-analysis  results.
nalysis  of  sensitivity  and  uniformity
he  sensitivity  analysis  was  performed  by  comparing  sepa-
ately  the  results  of  studies  of  good  and  poor  methodological
uality.8 The  search  for  statistical  heterogeneity  was  per-
ormed  by  successive  meta-analysis,  withdrawing  a  study  at
 time  until  the  identiﬁcation  of  the  heterogeneity  source.
he  heterogeneity  search  was  performed  in  meta-analysis
ith  I2 test  greater  than  30%.
rial  sequential  analysis
e  plan  to  use  the  trial  sequential  analysis  (TSA)  for  the
ariable  mortality.9 TSA  provides  limits  that  are  intended  to
onitor  the  values  for  the  magnitude  of  the  effect  being
valuated  in  an  intervention,  so  that  subsequent  meta-
nalysis  can  generate  reliable  results.9 A  part  of  the  TSA
alculation  provides  an  estimate  of  how  many  extra  partici-
ants  need  to  be  assessed  in  the  meta-analysis  for  the  results
o  be  reliable.9
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The  estimate  calculation  of  how  many  patients  would
e  needed  to  obtain  viable  conclusions  was  obtained  by
ultiplying  the  sample  size  calculation  result  for  individual
earches  performed  in  a  conventional  manner  by  an  adjust-
ent  factor  based  on  the  existing  diversity  (heterogeneity)
etween  the  studies.9 Conventional  calculation  to  estimate
he  sample  size  was  performed  by  considering  conventional
alues  (type  I  error  probability  of  5%  and  statistical  power  of
0%).  These  calculations  were  performed  using  the  late  mor-
ality  incidence  value,  seen  in  the  GA  group,  found  in  this
ystematic  review  and  aiming  at  a  relative  risk  reduction
f  25%.  The  adjustment  factor  based  on  diversity  used  was
0%,  considering  that  the  statistical  heterogeneity  above
his  value  is  considered  high.
esults
e  identiﬁed  3615  titles  and  abstracts  by  the  search  strat-
gy  and  also  by  analyzing  the  references  of  studies  that  were
elected  for  the  assessment  of  methodological  quality.  We
dentiﬁed  17  original  articles  that  met  the  inclusion  crite-
ia  of  this  systematic  review  (Fig.  1).10--26 The  total  number
f  patients  studied  in  the  17  articles  identiﬁed  was  2477.
he  Kappa  Index  Agreement  between  reviewers  was  0.92.
Databases
Pubmed (n=1602)
Central (n=1662)
Embase (n=285)
Lilacs (n=173)
References of included studies
References (n=433)
Reading titles and abstracts (n=3615)
Not selected (n=3553)
Full reading of selected articles (n=62)
Critical analysis of articles included (n=17)
Quantitative analysis of articles included (n=17)
Excluded articles and reasons (n=45)
Inadequate variables (n=32)
Population (cardiac valve and artery) (n=5)
Inadequate intervention (n=6)
Study type (n=1)
Inadequate description (n=1)
igure  1  Flowchart  of  the  included  and  excluded  studies
ccording  to  PRISMA  statement  recommendation.
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able  1  shows  a  summary  of  the  studies  included  in  the
eta-analysis.10--26
rimary  outcome
he  primary  outcome  was  assessed  in  11  original  articles
ith  different  follow-up  times.10--13,16,17,20,21,23,25,26 There-
ore,  the  studies  were  grouped  for  analysis  according  to  the
ollow-up  time  as  immediate  (during  hospitalization),  early
30  days),  and  late  (over  364  days).  There  was  no  statisti-
ally  signiﬁcant  difference  in  the  assessed  follow-up  times
Fig.  2).
The  forest  plot  shows  the  risk  difference  and  the  corre-
ponding  95%  CI  for  each  study  (Fig.  2).  It  is  observed  that
ll  95%  CI  crossed  the  line  of  statistical  invalidity.  The  dia-
ond  plot  in  the  various  follow-up  time  assessed  also  crossed
he  line  of  statistical  invalidity.  Considering  the  immedi-
te  mortality  a p-value  =  0.74  (RD  =  0.00;  95%  IC  =  −0.01  to
.01;  1274  participants).  Considering  the  early  mortality  a
-value  =  0.56  (RD  =  0.00;  95%  IC  =  −0.01  to  0.01;  714  par-
icipants).  Considering  the  late  mortality  a  p-value  =  0.24
RD  =  −0.01;  95%  IC  =  −0.03  to  0.01;  730  participants).  It  is
oncluded  that  there  was  no  statistically  signiﬁcant  differ-
nce  regarding  the  studied  parameter.  It  is  observed  that
here  was  no  statistical  heterogeneity  in  the  assessment
f  immediate  mortality  (I2 =  0%;  p  =  0.96),  early  mortality
I2 =  0%;  p  =  0.92),  and  late  mortality  (I2 =  0%;  p  =  0.66).
econdary  outcomes
he  secondary  outcome  arrhythmia  was  assessed  in  11
riginal  articles.10,19,21,24--26 The  analysis  in  the  original  arti-
les  was  performed  only  during  the  hospital  stay.  There
as  a  signiﬁcant  difference  in  the  parameter  analyzed
Fig.  3).
The  forest  plot  shows  the  relative  risk  and  the  corre-
ponding  95%  CI  for  each  study  (Fig.  3).  It  is  noted  that
he  95%  CI  of  3  studies  did  not  cross  the  line  of  statistical
nvalidity  indicating  that  NA  has  a  protective  effect  for  the
mergence  of  arrhythmias.10,12,21 The  diamond  plot  also  did
ot  cross  the  line  of  statistical  invalidity  showing  a  protec-
ive  effect  in  favor  of  NA.  This  analysis  p-value  was  equal
o  0.02  (RR  =  0.68;  95%  CI  =  0.50--0.93;  1363  participants).  It
s  concluded  that  there  was  no  statistically  signiﬁcant  dif-
erence  in  regarding  the  studied  parameter.  It  is  noted  that
here  was  statistical  heterogeneity  in  this  variable  assess-
ent  (I2 =  35%;  p  =  0.12).
The  secondary  outcome  stroke  was  assessed  in  three  orig-
nal  articles.12,21,23 The  analysis  in  the  original  articles  was
erformed  only  during  the  hospital  stay.  There  was  no  sta-
istically  signiﬁcant  difference  in  the  assessed  parameter
Fig.  4).
The  forest  plot  shows  the  relative  risk  and  the  corre-
ponding  95%  CI  for  each  study  (Fig.  4).  It  is  noted  that  all
5%  CI  of  the  3  original  articles  crossed  the  line  of  statisti-
al  invalidity  indicating  no  beneﬁcial  effect  in  the  NA  and
A  combination.  The  diamond  plot  also  crossed  the  line  of
tatistical  invalidity  showing  no  protective  effect  in  favor  of
A.  The  p-value  for  this  analysis  was  equal  to  0.62  (RR  =  0.79;
5%  CI  =  0.32--1.95;  1288  participants).  It  was  concluded  that
here  was  no  statistically  signiﬁcant  difference  regarding
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Table  1  Summary  of  studies  included  in  meta-analysis.
Authors  Publication  year  Quality  score  General/neuraxial  (n)  Drugs
Bakhtiary  et  al.10 2007  2  66/66  0.16%  ropivacaine,
sufentanil  1  g  mL−1,  CI
Berendes et  al.11 2003  3  37/36  0.5%  bupivacaine,
sufentanil  15  a  25  g,  CI
0.75%  bupivacaine
Caputo et  al.12 2001  3  117/119  0.5%  bupivacaine,  CI
0.125%  bupivacaine  and
0.0003%  clonidine
Fillinger et  al.13 2002  2  30/30  0.5%  bupivacaine,
morphine  20  b  kg−1,  CI
0.125%  bupivacaine
0.125%  and  morphine
Gurses et  al.14 2013  2  32/32  Levobupivacaine
0.075  mg  kg−1,  fentanyl
2 g  kg−1 CI
Jideus et  al.15 2001  1  96/45  0.5%  bupivacaine,  CI  0.2%
bupivacaine  and  sufentanil
Kurtoglu et  al.16 2009  2  42/34  NR
Mehta et  al.17 2004  4  47/53  Morphine  dose  of  8  g  kg−1
Onan  et  al.18 2013  1  20/20  0.25%  bupivacaine,  CI
Priestley et  al.19 2002  3  50/50  1%  ropivacaine,  fentanil
100  g,  CI  1%  ropivacaine
with  fentanil
Rajakaruna  et  al.20 2013  2  117/109  0.5%  bupivacaine,  CI
0.125%  bupivacaine  and
0.0003%  clonidine
Scott et  al.21 2001  3  202/206  0.5%  bupivacaine,  CI
0.125%  bupivacaine  and
0.0006%  clonidine
Shroff et  al.22 1997  3  9/12  Morphine  10  g  kg−1,
fentanil  25  g,  CI
Svircevic et  al.23 2011  2  329/325  0.125%  bupivacaine  and
morphine,  CI  0.125%
bupivacaine  and  morphine
Tenenbein et  al.24 2008  2  25/25  0.75%  ropivacaine,
hydromorphone  200  g,  CI
0.2%  ropivacaine  and
hydromorphone
Turker et  al.25 2005  5  23/23  Morphine  0.01  mg  kg−1
Vries  et  al.26 2002  2  30/30  0.25%  bupivacaine,
sufentanil  25  g  10  mL−1,
CI
ed.
G
s
N
9
t
s
hn, number of participants; CI, continuous infusion; NR, not report
the  assessed  parameter.  It  is  noted  that  there  was  no  sta-
tistical  heterogeneity  in  this  variable  assessment  (I2 =  0%;
p  =  0.41).
The  secondary  outcome  acute  myocardial  infarction  was
assessed  in  three  original  articles.12,23,26 The  analysis  in  the
original  articles  was  performed  only  during  the  hospital
stay.  There  was  no  statistically  signiﬁcant  difference  in  the
assessed  parameter  (Fig.  5).The  forest  plot  shows  the  relative  risk  and  the  corre-
sponding  95%  CI  for  each  study  (Fig.  5).  It  is  noted  that  all
95%  CI  of  the  three  original  articles  crossed  the  line  of  statis-
tical  invalidity  indicating  no  beneﬁcial  effect  in  the  NA  and
t
c
n
eA  combination.  The  diamond  plot  also  crossed  the  line  of
tatistical  invalidity  showing  no  protective  effect  in  favor  of
A.  The  p-value  of  this  analysis  was  equal  to  0.90  (RR  =  0.96;
5%  CI  =  0.52--1.79;  940  participants).  It  is  concluded  that
here  was  no  statistically  signiﬁcant  difference  regarding  the
tudied  parameter.  It  is  noted  that  there  was  no  statistical
eterogeneity  in  this  variable  assessment  (I2 = 0%;  p  =  0.61).
The  secondary  outcome  hospital  stay  was  assessed  in
hree  original  articles.14,18,26 The  analysis  in  the  original  arti-
les  was  performed  only  during  the  hospital  stay.  There  was
o  statistically  signiﬁcant  difference  in  the  assessed  param-
ter  (Fig.  6).
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Neuraxial anesthesia General anesthesia Risk difference
M-H, random, 95% CI
Risk difference
M-H, random, 95% CIEventsStudies
1.1.1 Immediate (hospitalization %)
1.1.2 Early (30 days)
Total Events Total Weight
Bakhtiary 2007 0 66 0 66 12.5% 0.00 [–0.03, 0.03]
Caputo 2011 1  109  0  117 17.5%  0.01 [–0.02, 0.03]
Fillinger 2002 1 30 0 30 1.4% 0.03 [–0.05, 0.12]
Kurtoglu 2009 0 34 0 42 4.1% 0.00 [–0.05, 0.05]
Mehta 2004 0 53 0 47 7.2% 0.00 [–0.04, 0.04]
Rajakaruna 2013 1 109 0 117 17.5% 0.01 [–0.02, 0.03]
Scott 2001 1 206 2 202 38.3% –0.01 [–0.02, 0.01]
Turker 2005 0 23 0 23 1.6% 0.00 [–0.08, 0.08]
Subtotal (95% CI)    630    644 100.0%  0.00 [–0.01, 0.01]
Total events 4 2
Heterogeneity: Qui2=1.95, gl=7 (p=0.96);  l2=0%
Test for overall effect: Z=0.33 (p=0.74)
Svircevic 2011 2  325  1  329 97.3%  0.00 [–0.01, 0.01]
Vries 2002 0 30 0 30 2.7% 0.00 [–0.06, 0.06]
Subtotal (95% CI) 355 359 100.0% 0.00 [–0.01, 0.01]
Total events 2 1
Heterogeneity: Qui2=0.01, gl=1 (p=0.92);  l2=0%
Test for overall effect: Z=0.58 (p=0.56)
Berendes 2003 1 36   3 37  0.0%  –0,05 [–0.16, 0.05]
Kurtoglu 2009 0 34 0 42 12.0% 0,00 [–0.05, 0.05]
Svircevic 2011 3  325  7  329 88.0%  –0,01 [–0.03, 0.01]
Subtotal (95% CI) 359 371 100.0% –0,01 [–0.03, 0.01]
Total events     3    7
Heterogeneity: Qui2=0.19, gl=1 (p=0.66); l2=0%
Test for overall effect: Z=1.18 (p=0.24)
1.1.3 Late (over 364 days)
M-H, Mantel-Haenszel; Random, random effect model; 95% CI, 95% confidence interval.
–0,1 –0.05 0.05 0.10
Favors neuraxial Favors general anesthesia
Test for subgroup differences: Qui2=1.89, gl=2 (p =0.40); l 2=0%
Figure  2  Evaluation  of  mortality.  M--H,  Mantel--Haenszel;  random,  random  effect  model;  95%  CI,  95%  conﬁdence  interval.
Neuraxial anesthesia General anesthesia Relative risk
M-H, random, 95% CI
Relative risk
M-H, random, 95% CIEventsStudies Total Events Total Weight
M-H, Mantel-Haenszel; random, random effect model; 95% CI, 95% confidence interval.
Bakhtiary 2007 2 66  18  66   4.2%  0.11 [0.03, 0.46]
Caputo 2011  23  109  43 117 19 .3%  0.57 [0.37, 0.89]
Fillinger 2002 7 30   7 30   8.5%  1.00 [0.40, 2.50]
Gurses 2013  4 32   5 32   5.5%  0.80 [0.24, 2.71]
Jideus 2001  13  45  29  96 15 .8%  0.96 [0.55, 1.66]
Kurtoglu 2009 0 34   1 42   1.0%  0.41 [0.02, 9.74]
Priestley 2002 11  50  10  50  11 .0%   1.10 [0.51, 2.36]
Scott 2001 21  206  45 202 17 .8%  0.46 [0.28, 0.74]
Tenenbein 2008 6 25   9 25   9.2%  0.67 [0.28, 1.59]
Turker 2005  3 23   4 23   4.5%  0.75 [0.19, 2.98]
Vries 2002  4 30   2 30   3.4%  2.00 [0.40,10.11]
Total (95% CI)
Total events 94
650
173
713 100% 0.68 [0.50,0.93]
0.02      0.1 1 10 50
Favors neuraxial Favors general anesthesiaHeterogeneity: Qui
2
=15.27,  gl=10 (p=0.12); I2=35%
Test for overall effect: Z=2.38 (p=0.02)
Figure  3  Evaluation  of  arrhythmia.  M--H,  Mantel--Haenszel;  random,  random  effect  model;  95%  CI,  95%  conﬁdence  interval.
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Neuraxial anesthesia General anesthesia
EventsTotal WeightTotalEvents
Relative risk
M-H, random, 95% CI
Relative risk
M-H, random, 95% CIStudies
Caputo 2011                                      2                 109                 2           117        21.2%  1.07 [0.15,7.49]
Scott 2001                                          2                 206                 6           202        31.8%    0.33 [0.07, 1.60]
Svircevic 2011                                    5                 325                 4           329        47.0%  1.27 [0.34, 4.67]
Total (95% CI) 640
129
648 100% 0.79 [0.32, 1.95]
Total events
Heterogeneity: Qui2=1.79, gl=2 (p=0.41); I2=0%
Test for overall effect: Z = 0,50 (p = 0,62)
0.01 0.1 1 10 100
Favors neuraxiall Favors general anesthesia
M-H, Mantel-Haenszel; random, random effect model; 95% CI, 95% confidence interval.
Figure  4  Evaluation  of  stroke.  M--H,  Mantel--Haenszel;  random,  random  effect  model;  95%  CI,  95%  conﬁdence  interval.
General anesthesiaNeuraxial anesthesia
EventsTotalEvents Total Weight
Relative risk
M-H, random, 95% CI
Relative risk
M-H, random, 95% CI
M-H, Mantel-Haenszel; random, random effect model; 95% CI, 95% confidence interval.
Caputo 2011                                      1                 109                 0           117       3.8%             3.22 [0.13, 78.17]
Svircevic 2011                                  17                 325              18            329     92.4%              0. 96 [0.50, 1.82]
Vries 2002                                          0                   30                1              30       3.8%               0.33 [0.01, 7.87]
Total (95% CI)
Total events
Heterogeneity: Qui2=0.98, gl=2 (p=0.61); I2=0%
Test for overall effect: Z=0.13 (p=0.90)
19
476 100%
18
 0.96 [0.52,1.79]464
0.005            0.1 1 10 200
Favors neuraxial Favors general anesthesia
Studies
Figure  5  Evaluation  of  acute  myocardial  infarction.  M--H,  Mantel--Haenszel;  random,  random  effect  model;  95%  CI,  95%  conﬁdence
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The  forest  plot  shows  the  mean  difference  and  the  corre-
sponding  95%  CI  for  each  study  (Fig.  6).  It  is  noted  that  two
95%  CI  of  the  three  original  articles  crossed  the  line  of  statis-
tical  invalidity  indicating  that  there  was  a  beneﬁcial  effect
in  the  NA  and  GA  combination.14,18 The  diamond  chart  did
not  cross  the  line  of  statistical  invalidity  showing  no  protec-
tive  effect  in  favor  of  NA.  The  p-value  of  this  analysis  was
equal  to  0.06  (MD  =  −1.94;  95%  CI  =  −3.99  to  0.12;  164  par-
ticipants).  It  was  concluded  that  there  was  no  statistically
signiﬁcant  difference  regarding  the  assessed  parameter.  It
is  noted  that  there  was  statistical  heterogeneity  in  this  vari-
able  assessments  (I2 =  95%;  p  <  0.00001).
The  secondary  outcome  length  of  intensive  care  unit  stay
was  assessed  in  two  original  articles.13,14 The  analysis  in
the  original  articles  was  performed  only  during  the  hospital
t
m
Neuraxial anesthesia
Studies Mean
Gurses 2013
Onan 2013
Vries 2002
4.9
6.1
5.9
1.5
0.3
2.4
32
20
30
8.8
7.2
6.6
1.7
1.1
3.3
32
20
30
34.2%
35.3%
30.5%
100%8282Total (95% CI)
Heterogeneity: Qui2=37.17,gl=2 (p<0.00001); I2=95%
Test for overall effect: Z = 1.85 (p=0.06)
IV, interval variable; random, random effect model; 95% CI, 95% co
SD Total Mean SD Total Weigh
General anesthesia
Figure  6  Evaluation  of  hospital  stay.  IV,  interval  variable;  randtay.  There  was  a statistically  signiﬁcant  difference  in  the
ssessed  parameter  (Fig.  7).
The  forest  plot  shows  the  mean  difference  and  the  cor-
esponding  95%  CI  for  each  study  (Fig.  7).  It  is  observed  that
ne  95%  CI  from  the  two  original  articles  crossed  the  line
f  statistical  invalidity  indicating  that  there  was  a  beneﬁ-
ial  effect  in  the  NA  and  GA  combination.14 The  diamond
lot  crossed  the  line  of  statistical  invalidity  indicating  that
here  was  a  protective  effect  in  favor  of  neuraxial  anes-
hesia.  The  p-value  of  this  analysis  was  less  than  0.00001
MD  =  −2.09;  95%  CI  =  −2.92  to  −1.26;  124  participants).  It
as  concluded  that  there  was  no  statistically  signiﬁcant  dif-
erence  regarding  the  studied  parameter.  It  is  noted  that
here  was  no  statistical  heterogeneity  in  this  variable  assess-
ent  (I2 =  0%;  p  =  0.67).
–3.90 [–4.69, –3.11]
–1.10 [–1.60, –0.60]
–0.70 [–2.16, 0.76]
–1.94 [–3.99, 0.12]
–10
Favors neuraxial Favors general anesthesia
–5 0 5 10
nfidence interval.
t
IV mean difference,
random, 95% CI
IV mean difference,
random, 95% CI
om,  random  effect  model;  95%  CI,  95%  conﬁdence  interval.
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Neuraxial anesthesia
Studies Média
31.7
1.5
21.3
1.6
30
32
30
 3.6
44
 1.8
30
32
0.2%
98.8%
6262 100%
1.70 [–15.79, 19.19]
–2.10 [–2.93, –1.27]
–2.09 [–2.92, –1.26]
Favors general anesthesiaFavors neuraxial
–20 –1 0 0 10 20
Total (95% CI)
Fillinger 2002
Gurses 2013
Heterogeneity: Chi2=0.18,gl=1 (p=0.67); I2=0%
Test for overall effect: Z=4.92 (p<0.00001)
IV, interval variable; random, random effect model; 95% CI, 95% confidence interval.
DP Total Média DP Total Peso
General anesthesia Weight IV mean
difference, random, 95% CI
Weight IV mean
difference, random, 95% CI
Figure  7  Evaluation  of  length  of  intensive  care  unit  stay.  IV,  interval  variable;  random,  random  effect  model;  95%  CI,  95%
conﬁdence interval.
Neuraxial anesthesia
Studies Events
32
35
Caputo 2011
Scott 2001
Total (95% CI)
Total events 67 50
100%315 319
27
23
109
206
117
 202
55.2%
44.8%
1.27 [0.82, 1.98]
1.49 [0.98, 1.90]
1.37 [0.98, 1.90]
Favors neuraxial Favors general anesthesia
0.05 0.2   1  5 20Heterogenidade: Chi2=0.23,gl=1 (p=0.63); I2=0%
Test for overall effect: Z=1.87 (p=0,06)
M-H, Mantel-Haenszel; random, random effect model; 95% CI, 95% confidence interval.
Total Events Total Weight
General anesthesia Relative risk M-H,
random, 95% CI
Relative risk M-H,
random, 95% CI
Figure  8  Evaluation  of  blood  transfusion.  M--H,  Mantel--Haenszel;  random,  random  effect  model;  95%  CI,  95%  conﬁdence
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The  secondary  outcome  blood  transfusion  was  assessed  in
wo  original  articles.12,21 The  analysis  in  the  original  articles
as  performed  only  during  the  hospital  stay.  There  was  no
tatistically  signiﬁcant  difference  in  the  assessed  parameter
Fig.  8).
The  forest  plot  shows  the  relative  risk  and  the  corre-
ponding  95%  CI  for  each  study  (Fig.  8).  It  is  noted  that  the
wo  95%  CI  of  the  original  articles  did  not  cross  the  line  of
tatistical  invalidity  indicating  that  there  was  no  beneﬁcial
ffect  in  the  NA  and  GA  combination.  The  diamond  plot  has
ot  cross  the  line  of  statistical  invalidity  indicating  no  pro-
ective  effect  in  favor  of  NA.  The  p-value  of  this  analysis
as  equal  to  0.06  (RR  =  1.37;  95%  CI  =  0.98--1.90;  634  par-
icipants).  It  is  concluded  that  there  was  no  statistically
igniﬁcant  difference  regarding  the  studied  parameter.  It
s  noted  that  there  was  no  statistical  heterogeneity  in  this
ariable  assessment  (I2 =  0%;  p  =  0.63).
The  secondary  outcome  quality  of  life  was  analyzed  in
ne  estudy.12 The  meta-analytic  calculations  could  not  be
erformed.  Individual  data  from  this  study  show  that  the
est  result  was  found  in  the  NA  group  combined  with  GA.
The  secondary  outcomes  reoperation  frequency,  degree
f  satisfaction,  and  postoperative  cognitive  dysfunction
ere  not  assessed  in  any  study  selected  for  quantitative
nalysis  of  the  results.
ensitivity  and  uniformity  analysishe  sensitivity  analysis  was  performed  for  the  primary
utcome  and  for  the  following  secondary  outcome  varia-
les:  arrhythmia,  stroke,  acute  myocardial  infarction.  The
n
a
sariables  length  of  hospital  stay,  length  of  stay  in  intensive
are  unit,  and  blood  transfusion  could  not  be  analyzed
ecause  the  studies  were  classiﬁed  in  the  same  category.
There  was  no  statistically  signiﬁcant  difference  between
tudies  of  good  and  bad  quality  regarding  the  variable
ortality.  Considering  the  group  of  good  quality  studies,
-value  =  0.55  (RD  =  0.01;  95%  CI  =  −0.01  to  0.03;  372  par-
icipants).  Considering  the  group  of  bad  quality  studies,
-value  =  0.40  (RD  =  0.00;  95%  CI  =  −0.01  to  0.01;  1208  par-
icipants).
The  arrhythmia  variable  showed  that  the  studies  of  good
uality  are  statistically  signiﬁcant,  those  of  poor  quality
ave  no  statistically  signiﬁcant  difference,  and  the  anal-
sis  of  all  the  articles  does  not  change  the  end  result,
onﬁrming  that  NA  associated  with  GA  reduces  the  inci-
ence  of  arrhythmias.  Considering  the  group  of  good  quality
tudies,  p-value  =  0.004  (RR  =  0.60;  95%  CI  =  0.43--0.85;  780
articipants).  Considering  the  group  of  bad  quality  studies,
-value  =  0.63  (RR  =  0.91;  95%  CI  =  0.62--1.33;  451  partici-
ants).  Considering  all  the  good  and  poor  quality  studies,
-value  =  0.002  (RR  =  0.69;  95%  CI  =  0.55--0.87;  1231  partici-
ants).
The  stroke  variable  showed  no  statistically  signiﬁcant
ifference  between  the  studies  of  good  and  bad  quality.
onsidering  the  group  of  good  quality  studies,  p-value  =  0.31
RR  =  0.53;  95%  CI  =  0.15--1.80;  634  participants).  Consid-
ring  the  group  of  bad  quality  studies,  p-value  =  0.72
RR  =  1.27;  95%  CI  =  0.34--4.67;  654  participants).The  acute  myocardial  infarction  variable  showed
o  signiﬁcant  difference  between  the  studies  of  good
nd  bad  quality.  Considering  the  group  of  good  quality
tudies,  p-value  = 0.47  (RR  =  3.25;  95%  IC  =  0.13--80.60;
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226  participants).  Considering  the  group  of  bad  quality
studies,  p-value  = 0.76  (RR  =  0.90;  95%  CI  =  0.47--1.75;  714
participants).
Statistical  heterogeneity  occurred  in  the  arrhythmia  and
hospital  stay  analyzes.  In  the  arrhythmia  variable  analysis,
the  successive  meta-analysis  method  allowed  the  identi-
ﬁcation  of  a  study  as  the  source  of  heterogeneity.10 The
inverted  funnel  plot  showed  that  this  study  is  responsible
for  publication  bias  and  its  exclusion  makes  the  analy-
sis  homogeneous  without  changing  the  beneﬁcial  effect
of  using  the  NA  and  GA  combination.  The  meta-analysis
result  without  the  study  responsible  for  the  publication  bias
shows  that,  from  this  analysis,  p-value  =  0.002  (RR  =  0.69;
95%  CI  =  0.55--0.87;  1231  participants;  I2 =  0%;  p  =  0.46).  The
original  article  responsible  for  the  source  of  statistical  het-
erogeneity  of  the  length  of  hospital  stay  variable  analysis
was  identiﬁed.14 The  statistical  heterogeneity  may  have  a
medical  explanation,  as  a  catheter  was  used  in  cervical
space  with  caudal-to-thoracic  segments  introduction,  unlike
other  studies  performing  thoracic  catheter  insertion.  The
analysis  without  the  study  identiﬁed  as  the  source  of  statisti-
cal  heterogeneity  shows  signiﬁcant  results,  p-value  <  0.0001
(MD  =  −1.06;  95%  CI  −1.53  to  −0.59;  100  participants),  and
favorable  to  the  use  of  NA.
Trial  sequential  analysis
The  TSA  could  not  be  performed  due  to  the  limitation  of  data
found  in  the  articles  included  in  this  systematic  review  for
the  mortality  variable.  The  low  frequency  of  the  event  and
the  limited  number  of  participants  limited  the  calculation.
The  number  of  studied  patients  required  for  the  meta-
analysis  results  to  be  considered  reliable  was  estimated.  The
event  rate  in  the  control  group  (GA  group)  of  this  system-
atic  review  was  2%  (7/371).  The  25%  relative  risk  reduction
reduced  this  value  to  1.5%.  The  sample  size  calculation
with  a  type  I  error  probability  of  5%  and  statistical  power
of  80%  indicated  the  need  for  4664  participants.  The  sam-
ple  size  was  multiplied  by  the  adjustment  factor  based  on
the  diversity  among  studies,  leading  to  an  estimated  9264
more  participants  to  make  our  conclusion  reliable  for  the
mortality  variable.
Discussion
Brieﬂy,  the  results  of  this  meta-analysis  are:  (a)  lack  of
statistical  signiﬁcance  between  the  two  anesthetic  tech-
niques  used  for  coronary  artery  bypass,  regarding  mortality;
(b)  lower  incidence  of  arrhythmias  when  NA  was  used;  (c)
shorter  length  of  stay  in  the  intensive  care  unit  when  NA  was
used.
There  are  some  limitations  in  this  systematic  review.
First,  we  note  the  existence  of  heterogeneity  among  studies
in  some  analyzes;  however,  the  strategy  used  for  the  analy-
sis  of  sensitivity  and  homogeneity  was  effective  to  identify
the  source  of  statistical  heterogeneity  that  was  explored
by  the  reviewers.  Second,  the  arrhythmia  variable  showed
statistical  difference  in  favor  of  NA,  but  excluding  the  stud-
ies  using  clonidine  in  neuraxial  blockade  and  not  using  it  in
the  group  receiving  GA  alone,  that  statistical  signiﬁcance
does  not  occur  demonstrating  that  possibly  the  beneﬁcial
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ffect  of  using  NA  for  coronary  artery  bypass  may  be  related
o  the  2-adrenergic  agonist  effect  of  this  drug  when  used
ia  epidural  route.  Third,  the  number  of  studies  used  in
he  analysis  of  the  length  of  stay  in  intensive  care  unit
ariable  was  small,  and  the  result  may  have  occurred  by
hance.
Stroke,  acute  myocardial  infarction,  hospital  stay,  and
lood  transfusion  variables  were  not  statistically  signiﬁcant
onsidering  the  data  from  the  studies  included  in  this  sys-
ematic  review.  The  analysis  of  these  variables  may  have
een  limited  by  the  small  number  of  identiﬁed  studies,  small
umber  of  events  reported  in  studies,  and  identiﬁcation  of
tudies  with  small  samples.  The  lack  of  statistically  signif-
cant  difference  may  be  due  to  the  small  statistical  power
resent  in  these  analyzes.
The  sensitivity  analysis  that  evaluated  the  results  of  good
nd  poor  quality  studies  was  not  a limitation  to  this  research,
s  the  separation  of  studies  to  perform  the  meta-analysis
id  not  change  the  ﬁnal  results  or  the  conclusions  drawn
rom  the  analyzes  of  the  full  set  of  original  articles.  The
omogeneity  analysis  of  the  length  of  hospital  stay  vari-
ble  showed  that  statistical  signiﬁcance  occurs  when  the
ource  of  statistical  heterogeneity  is  excluded  from  the
eta-analysis,  showing  that  the  result  for  this  variable  is
nbound.
Quality  of  life  was  evaluated  in  a  study.12 The  variable
resence  in  only  one  study  prevents  the  execution  of  the
eta-analysis  calculations.8 The  study  in  question  also  could
ot  have  been  included  in  the  analysis  because  it  assessed
nly  the  participants  who  lived  in  one  of  the  countries  par-
icipating  in  the  study,  and  this  could  be  considered  data
easurement  bias.8
Reoperation  frequency,  degree  of  satisfaction,  and
ostoperative  cognitive  dysfunction  variables  were  not  eval-
ated  in  the  included  studies,  highlighting  the  need  for  more
andomized  trials  with  adequate  statistical  power  and  good
ethodological  quality  to  evaluate  the  relevant  clinical
ariables.  A  clinical  trial  with  random  allocation  performed
ndividually  should  consider  an  adequate  statistical  power
or  its  execution.  Considering  the  5%  mortality  in  the  group
ndergoing  GA,  the  3%  mortality  in  the  NA  alone  group,
 statistical  power  of  80%,  and  a  type  I  error  probabil-
ty  of  5%,  it  is  needed  1500  participants  in  each  analysis
roup.
The  maximum  number  of  participants  assessed  in  this  sys-
ematic  review  for  the  mortality  variable  was  1274,  of  which
14  for  mortality  up  to  30  days  after  surgery  and  730  for
ate  mortality.  The  execution  of  part  of  the  TSA  calculation
ndicated  that  it  necessary  to  evaluate  9264  extra  partici-
ants.  Considering  the  execution  of  this  calculation  and  the
umber  of  study  participants,  we  note  that  the  number  of
articipants  was  small,  which  implies  the  existence  of  a  high
robability  for  the  presence  of  type  II  error  in  this  system-
tic  review  that  may  have  been  responsible  for  the  lack  of
tatistical  signiﬁcance  in  the  primary  outcome.
A  systematic  review  published  in  2009  evaluated  the  use
f  spinal  anesthesia  in  heart  surgery,  but  concluded  that
he  use  of  NA  was  unfavorable,  considering  the  mortality,
yocardial  infarction,  and  hospital  stay  variables.27 That
eview  analyzed  studies  in  the  setting  of  heart  surgery  and
ot  only  coronary  artery  bypass,  thus  differing  from  our  sys-
ematic  review.
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A  systematic  review  published  in  2011  evaluated  the  use
f  epidural  analgesia  in  heart  surgery.28 The  authors  con-
luded  that  the  use  of  NA  is  beneﬁcial,  considering  the
educed  risk  of  postoperative  supraventricular  arrhythmias
nd  respiratory  complications.  That  review  did  not  individ-
alize  data  for  coronary  artery  bypass.  The  authors  used
n  instrument  not  validated  to  assess  the  methodological
uality  of  the  included  studies,  contrary  to  this  systematic
eview  that  used  an  established  system  for  the  analysis  of
his  item.
A  systematic  review  published  in  2012  evaluated  the  use
f  epidural  anesthesia  in  heart  surgery.29 The  only  assessed
ariable  was  the  presence  of  atrial  ﬁbrillation,  but  the
esults  showed  marked  heterogeneity  whose  source  was
ot  identiﬁed  by  the  authors,  contrary  to  this  systematic
eview.
Our  study  has  emerged  as  an  attempt  to  optimize  the
esults  that  were  found  in  other  systematic  reviews  in  the  lit-
rature,  individualizing  the  data  for  coronary  artery  bypass
nd  to  update  the  knowledge  based  on  scientiﬁc  evidence
n  this  area  of  knowledge  in  order  to  assist  the  physician  in
aking  decisions  before  the  patient  when  choosing  the  anes-
hetic  technique.  From  this  systematic  review,  we  conclude
hat  the  combination  of  neuraxial  anesthesia  and  general
nesthesia  for  coronary  artery  bypass  showed  no  statistical
ifference  in  mortality  and  is  associated  with  a  lower  inci-
ence  of  postoperative  arrhythmias  and  shorter  length  of
tay  in  the  intensive  care  unit.
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